Download PDF
Der Klinikarzt 2019; 48(10): 396-401
DOI: 10.1055/a-1012-8170
Schwerpunkt
© Georg Thieme Verlag Stuttgart · New York

Arrhythmien bei Lungenerkrankungen

Ein Fokus auf COPD und obstruktives Schlafapnoe-Syndrom
Steffi Butz
1   II. Medizinische Klinik, Klinikum Coburg, Coburg
,
Sonia Busch
1   II. Medizinische Klinik, Klinikum Coburg, Coburg
,
Johannes Brachmann
1   II. Medizinische Klinik, Klinikum Coburg, Coburg
,
Aneida Vevecka
1   II. Medizinische Klinik, Klinikum Coburg, Coburg
› Author Affiliations
Further Information

Publication History

Publication Date:
17 October 2019 (online)

Also available at
    Permissions and Reprints

ZUSAMMENFASSUNG

Patienten mit Lungenerkrankungen haben häufig atriale und ventrikuläre Arrhythmien. Die Pathogenese dieser Arrhythmien ist komplex und kann viele Faktoren betreffen. Unter allen Lungenerkrankungen wird besonderes Augenmerk auf den Zusammenhang zwischen Arrhythmien bei Patienten mit COPD und obstruktivem Schlafapnoe-Syndrom gelegt. Dies sind die häufigsten Lungenerkrankungen, von denen angenommen wird, dass sie in Zukunft zunehmen.

 

  • Literatur

  • 1 Konecny T, Somers KR, Park JY. et al Chronic obstructive pulmonary disease as a risk factor for ventricular arrhythmias independent of left ventricular function. Heart Rhythm 2018; 15: 832-838
    CrossrefPubMedGoogle Scholar
  • 2 McCord J, Borzak S. Multifocal atrial tachycardia. Chest 1998; 113: 203-209
    CrossrefPubMedGoogle Scholar
  • 3 Buch P, Friberg J, Scharling H. et al Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J 2003; 21: 1012-1016
    CrossrefPubMedGoogle Scholar
  • 4 Soriano JB, Rigo F, Guerrero D. et al High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest 2010; 137: 333-340
    CrossrefPubMedGoogle Scholar
  • 5 Cazzola M, Bettoncelli G, Sessa E. et al Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration 2010; 80: 112-119
    CrossrefPubMedGoogle Scholar
  • 6 Bhatt SP. Dransfield MT Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res 2013; 162: 237-251
    CrossrefPubMedGoogle Scholar
  • 7 McCord J, Borzak S. Multifocal Atrial Tachycardia. Chest 1998; 113: 203-209
    CrossrefPubMedGoogle Scholar
  • 8 Caglar IM, Dasli T, Turhan Caglar FN. et al Evaluation of atrial conduction features with tissue doppler imaging in patients with chronic obstructive pulmonary disease. Clin Res Cardiol 2012; 101: 599-606
    CrossrefPubMedGoogle Scholar
  • 9 Korantzopoulos P, Kolettis TM, Galaris D. et al The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007; 115: 135-143
    CrossrefPubMedGoogle Scholar
  • 10 Ogi H, Nakano Y, Niida S. et al Is structural remodeling of fibrillated atria the consequence of tissue hypoxia?. Circ J 2010; 74: 1815-1821
    CrossrefPubMedGoogle Scholar
  • 11 Vestbo J, Hurd SS, Rodriguez-Roisin R. et al An overview of Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD). Zhonghua yi xue za zhi 2012; 92: 937-938
    PubMedGoogle Scholar
  • 12 Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res 2013; 162: 237-251
    CrossrefPubMedGoogle Scholar
  • 13 Terzano C, Romani S, Conti V. et al Atrial fibrillation in the acute, hypercapnic exacerbations of COPD. Eur Rev Med Pharmacol Sci 2014; 18: 2908-2917
    PubMedGoogle Scholar
  • 14 Grabicki M, Parysek H, Batura-Gabryel H. et al Comorbidities as an element of multidimensional prognostic assessment of patients with chronic obstructive pulmonary disease. J Physiol Pharmacol 2008; 59: 297-301
    PubMedGoogle Scholar
  • 15 Roh SY, Choi JI, Lee JY. et al Catheter ablation of atrial fibrillation in patients with chronic lung disease. Circ Arrhythm lectrophysiol 2011; 4: 815-822
    PubMedGoogle Scholar
  • 16 Gu J, Liu X, Tan H. et al Impact of chronic obstructive pulmonary disease on procedural outcomes and quality of life in patients with atrial fibrillation undergoing catheter ablation. J Cardiovasc Electrophysiol 2013; 24: 148-154
    CrossrefPubMedGoogle Scholar
  • 17 Pisters R, Nieuwlaat R, Prins MH. et al Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012; 14: 666-674
    CrossrefPubMedGoogle Scholar
  • 18 Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004; 125: 2309-2321
    CrossrefPubMedGoogle Scholar
  • 19 Huerta C, Lanes SF, García Rodríguez LA. Respiratory medications and the risk of cardiac arrhythmias. Epidemiology 2005; 16: 360-366
    CrossrefPubMedGoogle Scholar
  • 20 Adeloye D, Chua S, Lee C. et al Global Health Epidemiology Reference Group (GHERG). Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health 2015; 5: 020415
    CrossrefPubMedGoogle Scholar
  • 21 Wood-Baker R, Cochrane B, Naughton MT. Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment. Intern Med J 2010; 40: 94-101
    CrossrefPubMedGoogle Scholar
  • 22 Kuralay E, Cingöz F, Kiliç S. et al Supraventricular tachyarrythmia prophylaxis after coronary artery surgery in chronic obstructive pulmonary disease patients (early amiodarone prophylaxis trial). Eur J Cardiothorac Surg 2004; 25: 224-230
    CrossrefPubMedGoogle Scholar
  • 23 Du Q, Sun Y, Ding N. et al Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies. PLOS ONE 2014; 9: e113048
    CrossrefPubMedGoogle Scholar
  • 24 Gami AS, Olson EJ, Shen WK. et al Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 2013; 62: 610-616
    CrossrefPubMedGoogle Scholar
  • 25 Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52: 490-494
    CrossrefPubMedGoogle Scholar
  • 26 May AM, Van Wagoner DR, Mehra R. OSA and Cardiac Arrhythmogenesis: Mechanistic Insights. Chest 2017; 151: 225-241
    CrossrefPubMedGoogle Scholar
  • 27 Baranchuk A. Sleep apnea, cardiac arrhythmias, and conduction disorders. J Electrocardiol 2012; 45: 508-512
    CrossrefPubMedGoogle Scholar
  • 28 Patel N, Donahue C, Shenoy A. et al Obstructive sleep apnea and arrhythmia: A systemic review. Int J Cardiol 2017; 228: 967-970
    CrossrefPubMedGoogle Scholar
  • 29 Mehra R, Benjamin EJ, Shahar E. et al Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173: 910-916
    CrossrefPubMedGoogle Scholar
  • 30 Neilan TG, Farhad H, Dodson JA. et al Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc 2013; 2: e000421
    PubMedGoogle Scholar
  • 31 Fein AS, Shvilkin A, Shah D. et al Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62: 300-305
    CrossrefPubMedGoogle Scholar
  • 32 Naruse Y, Tada H, Satoh M. et al Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm 2013; 10: 331-337
    CrossrefPubMedGoogle Scholar
  • 33 Qureshi WT, Nasir UB, Alqalyoobi S. et al Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea. Am J Cardiol 2015; 116: 1767-1773
    CrossrefPubMedGoogle Scholar
  • 34 Bitter T, Westerheide N, Prinz C. et al Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 2011; 32: 61-74
    CrossrefPubMedGoogle Scholar
  • 35 Serizawa N, Yumino D, Kajimoto K. et al Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol 2008; 102: 1064-1068
    CrossrefPubMedGoogle Scholar
  • 36 Garrigue S, Pépin JL, Defaye P. et al High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation 2007; 115: 1703-1709
    CrossrefPubMedGoogle Scholar
  • 37 Simantirakis EN, Schiza SI, Marketou ME. et al Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a longterm evaluation using an insertable loop recorder. Eur Heart J 2004; 25: 1070-1076
    CrossrefPubMedGoogle Scholar
  • 38 van Oosten EM, Furqan MA, Redfearn DP. et al Sleep apnea does not predict atrial flutter recurrence after atrial flutter ablation. J Interv Card Electrophysiol 2012; 34: 73-78
    CrossrefPubMedGoogle Scholar